Author Guidelines

Author Guideline

Please click here for the template


The incoming manuscripts will be sent to peer-reviewers who are competent in the area of the related topic. Reviewing process for each manuscript takes 10 weeks. Decision made whether the manuscript is rejected, considered to be published upon revision or accepted for publication will be informed to the authors no later than 3 weeks after receiving the comments from the reviewers. The revised manuscript should be sent back to secretariat of IJPCR no later than 2 weeks. Editorials are responsible for all editing before publication.


The manuscript, including tables, figures, and references should bewritten in English and prepared in Times New Roman with normal margin, 12 font size and 1.5 spaces on A4 (21.5 cm x 28 cm) paper with maximum of 12 pages.


Title page consists of the title of the manuscript, full names of authors with the highest academic degrees, affiliations, mailing addresses, telephone and fax numbers, and e-mail address of the corresponding author. The title should be specific, concise, and informative, clearly related to the aim of the study,written with UPPERCASE and BOLD, and consist of not more than 20 words without abbreviations.


Abstract consists of objective, methods, results, and conclusion. It should contain not more than 250 words. Keywords contain 3 to 5 words.


Manuscript text consists of introduction, materials and methods, results, discussion, and conclusion.


The introduction provides information on what is known, believed, and unknown about the topic, findings of the relevant studies, and the importance of the study. The objective of the study must be stated in a single sentence in the last paragraph of the introduction.


Ethical clearance associated with the study must be included. Explains design of the study, how the data were obtained and analyzed. The method must be clearly described to allow the reproduction of the procedures. Specifications of the instrument, drugs, and chemicals should be mentioned.


Describes what was found and answers to the objective of the study.


Tables and figures should be placed after the reference section.The title of a table (with a sentence case) should briefly identify the table and not contain explanatory materials. This should be placed at the top of the table. An explanatory footnote is placed on the table’s note not on table’s title. The table is constructed with subhead and without left and right borders.

Figures should be placed on separate pages with number according to their appearance. A figure’s name (with a sentence case) is placed at its bottom.


Describe what the results of the study mean in relation to what was previously known about the subject. Indicate how the results relate to expectations and to the literatures previously cited. Describes the implications of the finding and compared to what were obtained by previous researchers


The conclusion is linked back to the aims of the study.


Explains who supported the research and provided the funding.


Conflict of interest must be declared by the authors.


References ensure that the previous findings were recognized. References should be written in accordance with the Vancouver referencing style (number in the order in which they first appear in the text). List the first six authors. When there are more than six authors, list the first six authors followed by et al. Place priority for the last ten years published articles. Use citation manager such as Mendeley or EndNote to cite your references.


  1. Article

Manley HJ, Cannella CA, Bailie GR, St Peter WL. Medication-related problems in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005;46(4):669-80.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52.

  1. Book

DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey L. Pharmacotherapy: a pathophysiologic approach 7th Ed. New York: The McGraw-Hill Companies Inc; 2008.

  1. Thesis and dissertation

Dalimunthe A. Evaluasi efek fraksi n-heksan, etil asetat dan etanoldaunpuguntano[i-[2](PicriafelterraeLour.) terhadap sistim kardiovasculer tikus (disertasi). Medan: Universitas Sumatera Utara; 2016.

  1. Proceeding

Nasution A, Syed sulaiman SA, Shafie AA.Drug-related problems and length of stay in the management of infection in patients with chronic kidney disease. Proceeding in ISPOR 5th Asia-Pacific Conference, 2012 September 2-4;Taipei, Taiwan.

  1. Online

Medscape Reference. Assessed online June 16th. Available from:

Publication Charge 

No publication charge needed (free)